Adenitis due to BCG vaccine: a case report
DOI:
https://doi.org/10.32385/rpmgf.v30i5.11389Keywords:
BCG Vaccine, LymphadenitisAbstract
Introduction: The Portuguese national vaccination plan recommends the Bacillus Calmette–Guérin (BCG) vaccine against tuberculosis for all newborn babies, except if there are specific contraindications. The main complication of BCG vaccine is lymphadenitis that can occur within 6 months after vaccination. Case description: A two-month old infant born after a full-term pregnancy presented at a routine consultation with left axillary lymphadenitis. The rest of the physical examination was normal. A diagnosis of BCG lymphadenitis diagnosis was made and the patient was referred to the local emergency service for observation. Conservative treatment was recommended. Faced with large lymphadenopathy, signs of inflammation, and the baby’s distress, the mother made frequent visits to the health center to show the evolution of the adenitis and to ask whether anything else could be done, aside from the administration of the analgesics. The child presented again with fluctuation and spontaneous drainage of the lymph nodes after 3 weeks. Eventually all symptoms resolved. The child was seen at 18 months old of age with a healed scar in the left axilla. Commentary: This case demonstrates the benign nature of BCG lymphadenitis. The vast majority of cases require conservative treatment. Referral is necessary only if there are complications that might require aspiration or surgical drainage. It can be difficult to reassure parents when presented with such a striking condition and the recommended course of action is analgesia and patience, as symptoms resolve spontaneously.Downloads
Downloads
Published
Issue
Section
License
The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.
The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.